Q1 Scientific’s Post

Enhance your knowledge on Skin dynamics: implications for eczema. New CPD module available now. Learn to counsel patients and caregivers about the optimal use of emollients. Plus it counts towards your revalidation with the General Pharmaceutical Council. 🌎https://lnkd.in/g5VFXR2R  

Piggybacking off of our recent blog article on patents, this piece from Pharmaceutical Technology highlights the use of deceptive or "bad faith" patents explicitly designed to extend patent exclusivity for brand-name manufacturers and prevent generic drug entry into the market. Learn more about evergreening and other tactics used to stall competition and strategies to address the abuse of the patent system. https://lnkd.in/eam9h7wv

Are you new to pharmaceutical ordering? Let Bound Tree help! Join us today at 1PM EDT, for an informative webinar to discuss how to enroll and order Class II controlled substances electronically. Topics covered: • Overview of the registration process • Benefits of CSOS Register Now: https://lnkd.in/gwcMAtgE

Are you new to pharmaceutical ordering? Let Bound Tree help! Join us, July 11 at 1PM EDT, for an informative webinar to discuss how to enroll and order Class II controlled substances electronically. Topics covered: • Overview of the registration process • Benefits of CSOS Register Now: https://lnkd.in/gwcMAtgE

Maintaining CSA Compliance in REDCap will ensure that electronic records and signatures used in pharmaceutical research are trustworthy, reliable, and equivalent to paper records. Check out this blog post (https://lnkd.in/d3T76eaA) to read about the best practices to maintain CSA Compliance in REDCap.

Want to understand the Gross-to-Net bubble? Check out William Roth's feature column in Pharmaceutical Commerce Magazine. The first part is out now: https://lnkd.in/erZGJkPn

Discover real-world impact on medical practice with Clinical Guidelines data in Altmetric. Altmetric now tracks Clinical Guidelines, offering valuable insights into the long-term influence of pharmaceutical and medical research. Monitor how your published work shapes clinical practices worldwide!🌐 Learn more: https://lnkd.in/gX989bwt

Webinar – Future-proof your drug development investment with robust IP search strategies Join Managing IP and CAS for a webinar on July 24 to learn how a strong intellectual property search strategy can ensure your pharmaceutical substance succeeds where others fail http://spr.ly/60479HZP9 In this webinar, experts Anne Marie Clark, Ph.D., senior patent searcher at CAS, and Heidi Berven, Ph.D., a partner at Honigman, will share best practices for intellectual property (IP) searching, including: - Essential novelty searches for pharmaceutical substances; - Tips for advanced IP search strategies and how they help to protect your research investment; and - The importance and hallmarks of trustworthy IP tools and partners. Register here to level up your pharmaceutical IP search strategy. http://spr.ly/60419HZPl

Free webinar next week! Future-proof your drug development investment with robust IP search strategies Learn how a strong intellectual property search strategy can ensure your pharmaceutical substance succeeds where others fail http://spr.ly/6044imD2w In this webinar, experts Anne Marie Clark, Ph.D., senior patent searcher at CAS, and Heidi Berven, Ph.D., a partner at Honigman LLP, will share best practices for intellectual property (IP) searching, including: - Essential novelty searches for pharmaceutical substances; - Tips for advanced IP search strategies and how they help to protect your research investment; and - The importance and hallmarks of trustworthy IP tools and partners. Register here to level up your pharmaceutical IP search strategy. http://spr.ly/6047imD2d

In our September newsletter, Tahir Amin discusses: 🔵🔴 How either party can lower drug prices 💊 A new report from Accountable.US detailing how the manufacturers of the ten drugs on Medicare’s price negotiation list systematically abused the patent system ✍️ Wayne Brough’s new R Street Institute essay on how to address the pharmaceutical industry’s abuse of the U.S. patent system Read the newsletter: https://lnkd.in/eDmZFVtk